EquityZen Growth Technology Fund LLC - Series 2170
Raised
$1M
Investors
45
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2170 is a Delaware LLC filed by EquityZen Advisors on 2025-11-06, raising $1.2M from 45 investors under Rule 506(b) and Section 3(c)(1). The offering has a $10K minimum investment and is part of EquityZen's pre-IPO investment platform with 1,889 related EDGAR entities.
This pre-IPO fund operates under the standard 506(b)/3(c)(1) exemption pattern typical of EquityZen's series structure, with a $10K minimum positioning it as retail-accessible compared to many private growth equity vehicles that require $100K+ minimums. The investor count and deal size are consistent with the platform's SPV-per-company model for secondary shares in late-stage private companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
